Efficacy and safety of bispecific antibodies therapy for relapsed or refractory multiple myeloma: a systematic review and meta-analysis of prospective clinical trials

Overview of attention for article published in Frontiers in immunology, February 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 6 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 34,303 followers.

Efficacy and safety of bispecific antibodies therapy for relapsed or refractory multiple myeloma: a systematic review and meta-analysis of prospective clinical trials https://t.co/f7rhS8H0B0

14 Mar 2024

Reply Repost Favourite

https://t.co/Vvck1ZOTME

03 Mar 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Efficacy and safety of bispecific antibodies therapy for relapsed or refractory multiple myeloma: a systema…

28 Feb 2024

Reply Repost Favourite

New Research: Efficacy and safety of bispecific antibodies therapy for relapsed or refractory multiple myeloma: a systematic review and meta-analysis of prospective clinical trials: Objective Bispecific antibody (BsAbs) therapy represents a… https://t.co/

28 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.